Posts Tagged ‘investor perspective’

First the disclaimer: I am not an investor myself, but I have worked with some. I will thus keep this short. Here is the most often heard perspective on investing in life science/medical innovation: “ It is very risky”. Suffice to say that there has been more than a year since the last biotech IPO (no IPOs in 2008), the venture investment in biotech has decreased significantly, and the current economic circumstances are not likely to improve this situation. It is not business as usual and it should not be – that is what brought us here. So, maybe because I am the optimist type, I can stop wondering: isn’t this the best time to invest in innovation?!?

Read Full Post »

%d bloggers like this: